Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study
- 1 November 1996
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 135 (5) , 752-757
- https://doi.org/10.1111/j.1365-2133.1996.tb03885.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvementJournal of the American Academy of Dermatology, 1995
- A randomized, double‐blind, 24‐week controlled study of low‐dose cyclosporine versus chloroquine for early rheumatoid arthritisArthritis & Rheumatism, 1994
- Cyclosporin versus Etretinate: Italian Multicenter Comparative Trial in Severe Plaque-Form PsoriasisDermatology, 1993
- Cyclosporine in psoriasis: A multicenter dose-finding study in severe plaque psoriasisJournal of the American Academy of Dermatology, 1992
- Cyclosporine for Plaque-Type PsoriasisNew England Journal of Medicine, 1991
- Cyclosporin A in psoriatic arthritis: an open study.Annals of the Rheumatic Diseases, 1990
- Low-dose cyclosporin versus placebo in patients with rheumatoid arthritisThe Lancet, 1990
- Cyclosporine in the treatment of psoriatic arthritisArchives of Dermatology, 1989
- Low-dose cyclosporin A in severe psoriasis. A double-blind studyBritish Journal of Dermatology, 1988
- Cyclosporine improves psoriasis in a double-blind studyJAMA, 1986